Skip to content

Netherlands logo

Main menu
    • About us
    • Our focus
    • Our products
    • Business development
    • Our leaders
    • Our culture
    • Policies & positions
    • Environmental, social & governance
    • Diversity, equity, inclusion & belonging
    • News
    • Media
  • Join our team

Contact Us

Back
Change Language
  • Nederlands
Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Organon & Women’s Health – from Legacy to Future Promise

Save Print

December 12, 2022 8:43 am EDT

Celebrate International Women’s Day (on March 8) together with senior leaders in health and policy at our event: ‘Organon & Women’s Health – From Legacy to Future Promise’.

  • Learn about Organon’s legacy in women’s health in The Netherlands
  • Engage in discussions with international advocates and experts on closing health gaps for women
  • Join us as we kick off our 100-year anniversary celebrations with the opening of the Experience Center

Wednesday March 8, 2023 (International Women’s Day)

  • 09.30 – 10.00 Arrivals / Doors open & registration
  • 10:00 – 12:15 Official program
  • 12:15 – 13:30 Networking and visit the Experience Centre
  • Location: Organon, Molenstraat 110, 5342 CC Oss


Didn’t receive an invitation and want to sign up? Please contact us: communications_benelux@organon.com


Speakers at this unique event are:

  • Wenny Raaijmakers, Site Lead Organon Oss
    “Welcome to Organon!”
    Wenny is an experienced Plant Manager with many years of experience in the pharmaceutical industry. She leads Organon Oss, our largest production site worldwide. (LinkedIn)
  • Wobine Buijs-Glaudemans, Mayor City of Oss
    “A Women’s Health Legacy in Oss”
    Wobine is mayor of the city of Oss, that has been a home for pharma for hundred years now and still accommodates a large part of the employment in this sector. (LinkedIn)
  • Petra Willems, Managing Director Organon Benelux:
    “Our promise”
    Petra is an experienced business leader with a long and successful 30-year track record at MSD across many therapeutic areas before she was announced Managing Director of Organon Benelux in June 2021. (LinkedIn)
  • Aleisha Woodward, Deputy Chief of Mission of the United States Mission to the Netherlands:
    “US and Dutch Connections in Life Sciences and Women’s Health”
    Aleisha is a career member of the U.S. Senior Foreign Service, began her assignment in the Netherlands as Deputy Chief of Mission in June 2022. (LinkedIn)
  • Jannet Vaessen, Director Women Inc.:
    “The journey of women towards better health in the Netherlands”
    WOMEN Inc. improves the position of women in the Netherlands; we strive for a society with equal opportunities for everyone, regardless of gender or sex. (LinkedIn)

Panel discussion on ‘Closing the Gap in Women’s Health’ with:

  • Prof. Dr. Angela Maas – Emeritus professor of women’s cardiology (LinkedIn)
  • Prof. Dr. Annemiek Nap – Head of department Obstetrics & Gynaecology, Professor at RadboudUMC (LinkedIn)
  • Samira Rafaela – Member of European Parliament (LinkedIn)
  • Michael Pergine – Head of Global Policy, Government Relations and ESG Strategy at Organon (LinkedIn)
  • and others.


“Ik zet me in voor de gezondheid van vrouwen, niet omdat iets me frustreert of raakt, maar omdat er gewoon nog werk te doen is. Er zijn 4 miljard meisjes en vrouwen op de wereld. Als je hun gezondheid verbetert, komt dat ons allemaal ten goede.”

Click here to read the Dutch interview with Petra Willems in FD (January 11, 2023).


Meet Organon, a new company with 100 years of experience.

The Experience center will be officially opened during the event at International Women’s Day. You can be one of the early visitors, at March 8, 2023!


Click here to watch the “Making of the Oss mural”


Didn’t receive an invitation and want to sign up? Please contact us: communications_benelux@organon.com

What can we help you find?

Search for:
Netherlands logo
  • Forward-Looking Statement
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept